title: [Clinical signification and evaluation of PIVKA-II in hepatocellular carcinoma].
authors: A
authors: A
authors: Matsushima
authors: M
authors: M
authors: Enomoto
authors: Y
authors: Y
authors: Yokoo
authors: M
authors: M
authors: Arai
authors: T
authors: T
authors: Kobayashi
authors: F
authors: F
authors: Okuno
authors: Y
authors: Y
authors: Hirano
authors: K
authors: K
authors: Sujita
authors: S
authors: S
authors: Eto
authors: T
authors: T
authors: Takagi
mesh_terms: D000368:Aged; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000097:blood*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis*; D006801:Humans; D007124:Immunoenzyme Techniques; D008113:Liver Neoplasms / Q000175:diagnosis*; D008297:Male; D011498:Protein Precursors / Q000032:analysis*; D011516:Prothrombin / Q000032:analysis*; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D015415:Biomarkers; D014408:Biomarkers, Tumor; D011498:Protein Precursors; D000509:alpha-Fetoproteins; C008208:acarboxyprothrombin; D011516:Prothrombin